Canada markets open in 7 minutes

Helix BioPharma Corp. (HBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.17000.0000 (0.00%)
At close: 09:30AM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 36.83M
Enterprise Value 36.05M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)59.22
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -6.10

Trading Information

Stock Price History

Beta (5Y Monthly) -0.74
52-Week Change 3-19.05%
S&P500 52-Week Change 327.79%
52 Week High 30.2600
52 Week Low 30.1500
50-Day Moving Average 30.2014
200-Day Moving Average 30.2139

Share Statistics

Avg Vol (3 month) 315.65k
Avg Vol (10 day) 312k
Shares Outstanding 5216.67M
Implied Shares Outstanding 6216.67M
Float 8177.45M
% Held by Insiders 121.66%
% Held by Institutions 10.00%
Shares Short (Feb 15, 2024) 412.78k
Short Ratio (Feb 15, 2024) 41.09
Short % of Float (Feb 15, 2024) 40.01%
Short % of Shares Outstanding (Feb 15, 2024) 40.01%
Shares Short (prior month Jan 15, 2024) 43.7k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 31, 2023
Most Recent Quarter (mrq)Oct 31, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-111.88%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-5.94M
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.64M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.46
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-5.99M
Levered Free Cash Flow (ttm)-7.41M